Articles with public access mandates - Meredyth G Ll Wilkinson - Wellcome TrustLearn more
NoteFor this mandate, articles should be available from specific locations.
Available based on mandate: 6
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
KW Ng, N Faulkner, GH Cornish, A Rosa, R Harvey, S Hussain, R Ulferts, ...
Science 370 (6522), 1339-1343, 2020
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor …
CJM Piper, MGL Wilkinson, CT Deakin, GW Otto, S Dowle, CL Duurland, ...
Frontiers in immunology 9, 1372, 2018
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis
CT Deakin, J Bowes, LG Rider, FW Miller, LM Pachman, H Sanner, ...
Human molecular genetics 31 (14), 2471-2481, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
MGL Wilkinson, D Moulding, TCR McDonnell, M Orford, C Wincup, ...
Annals of the Rheumatic Diseases 82 (5), 658-669, 2023
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
CT Deakin, GH Cornish, KW Ng, N Faulkner, W Bolland, J Hope, A Rosa, ...
Med 2 (9), 1093-1109. e6, 2021
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective
MGL Wilkinson, W Wu, K O’Brien, CT Deakin, LR Wedderburn, ...
Rheumatology Advances in Practice 5 (3), rkab058, 2021
Publication and funding information is determined automatically by a computer program